Lv1
30 积分 2026-07-14 加入
Discovery and In Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases
2天前
已完结
New Iron Twist to ChloroquineUpgrading Antimalarials with Immunomodulatory and Antimicrobial Features
2天前
已完结
Targeting Toll-like Receptors 7, 8, and 9 Inhibition in Systemic Lupus Erythematosus: Therapeutic Advance and Future Directions
2天前
已完结
皖公网安备34019202002308
